BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Richards EM, Pepine CJ, Raizada MK, Kim S. The Gut, Its Microbiome, and Hypertension. Curr Hypertens Rep 2017;19:36. [PMID: 28444579 DOI: 10.1007/s11906-017-0734-1] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
Number Citing Articles
1 Katsimichas T, Antonopoulos AS, Katsimichas A, Ohtani T, Sakata Y, Tousoulis D. The intestinal microbiota and cardiovascular disease. Cardiovascular Research 2019;115:1471-86. [DOI: 10.1093/cvr/cvz135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
2 Souders CL 2nd, Zubcevic J, Martyniuk CJ. Tumor Necrosis Factor Alpha and the Gastrointestinal Epithelium: Implications for the Gut-Brain Axis and Hypertension. Cell Mol Neurobiol 2021. [PMID: 33594519 DOI: 10.1007/s10571-021-01044-z] [Reference Citation Analysis]
3 Hsu CN, Tain YL. Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins. Int J Mol Sci 2021;22:2298. [PMID: 33669059 DOI: 10.3390/ijms22052298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wang Z, Shen Y, Hao J, Chen Q, Jin Y. Two Zn(II) coordination polymers: Luminescent sensing property and treatment capacity against stable coronary heart disease by regulating E.coli abundance and IL-17 content. Journal of Solid State Chemistry 2020;287:121316. [DOI: 10.1016/j.jssc.2020.121316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lewis-Mikhael AM, Davoodvandi A, Jafarnejad S. Effect of Lactobacillusplantarum containing probiotics on blood pressure: A systematic review and meta-analysis. Pharmacol Res 2020;153:104663. [PMID: 31987993 DOI: 10.1016/j.phrs.2020.104663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
6 Sun Y, Baptista LC, Roberts LM, Jumbo-Lucioni P, McMahon LL, Buford TW, Carter CS. The Gut Microbiome as a Therapeutic Target for Cognitive Impairment. J Gerontol A Biol Sci Med Sci 2020;75:1242-50. [PMID: 31811292 DOI: 10.1093/gerona/glz281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
7 Boakye AA, Adedia D, Hunkpe GK, Ampomah Carr RA, Adanusahall VFA, Agbenyo BS, Duedu KO, Moreira TMM. Comparative Assessment of the Utility of Anthropometric and Bioelectrical Impedance Indices as Potential Predictors of Hypertension within a Ghanaian Adult Population: A Cross-Sectional Study. International Journal of Hypertension 2022;2022:1-9. [DOI: 10.1155/2022/2242901] [Reference Citation Analysis]
8 Chi C, Li C, Wu D, Buys N, Wang W, Fan H, Sun J. Effects of Probiotics on Patients with Hypertension: a Systematic Review and Meta-analysis. Curr Hypertens Rep 2020;22. [DOI: 10.1007/s11906-020-01041-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
9 Xie D, Shen Y, Su E, Du L, Xie J, Wei D. The effects of angiotensin I-converting enzyme inhibitory peptide VGINYW and the hydrolysate of α-lactalbumin on blood pressure, oxidative stress and gut microbiota of spontaneously hypertensive rats. Food Funct 2022. [PMID: 35171185 DOI: 10.1039/d1fo03570c] [Reference Citation Analysis]
10 Yang T, Aquino V, Lobaton GO, Li H, Colon-Perez L, Goel R, Qi Y, Zubcevic J, Febo M, Richards EM, Pepine CJ, Raizada MK. Sustained Captopril-Induced Reduction in Blood Pressure Is Associated With Alterations in Gut-Brain Axis in the Spontaneously Hypertensive Rat. J Am Heart Assoc 2019;8:e010721. [PMID: 30755073 DOI: 10.1161/JAHA.118.010721] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 13.5] [Reference Citation Analysis]
11 Meijers B, Evenepoel P, Anders H. Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol 2019;15:531-45. [DOI: 10.1038/s41581-019-0172-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 14.0] [Reference Citation Analysis]
12 Wu H, Lam TYC, Shum TF, Tsai TY, Chiou J. Hypotensive effect of captopril on deoxycorticosterone acetate-salt-induced hypertensive rat is associated with gut microbiota alteration. Hypertens Res 2021. [PMID: 34857899 DOI: 10.1038/s41440-021-00796-x] [Reference Citation Analysis]
13 Li S, Shao Y, Li K, Huangfu C, Wang W, Liu Z, Cai Z, Zhao B. Vascular Cognitive Impairment and the Gut Microbiota. JAD 2018;63:1209-22. [DOI: 10.3233/jad-171103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Sharma RK, Oliveira AC, Yang T, Karas MM, Li J, Lobaton GO, Aquino VP, Robles-Vera I, de Kloet AD, Krause EG, Bryant AJ, Verma A, Li Q, Richards EM, Raizada MK. Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension. Hypertension 2020;76:206-16. [PMID: 32418496 DOI: 10.1161/HYPERTENSIONAHA.120.14931] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
15 Samson R, Ayinapudi K, Le Jemtel TH, Oparil S. Obesity, Hypertension, and Bariatric Surgery. Curr Hypertens Rep 2020;22:46. [PMID: 32591918 DOI: 10.1007/s11906-020-01049-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Donertas Ayaz B, Zubcevic J. Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide. Pharmacol Res 2020;153:104677. [PMID: 32023431 DOI: 10.1016/j.phrs.2020.104677] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
17 Hsu CN, Hou CY, Lee CT, Chang-Chien GP, Lin S, Tain YL. Maternal 3,3-Dimethyl-1-Butanol Therapy Protects Adult Male Rat Offspring against Hypertension Programmed by Perinatal TCDD Exposure. Nutrients 2021;13:3041. [PMID: 34578924 DOI: 10.3390/nu13093041] [Reference Citation Analysis]
18 Weber GJ, Foster J, Pushpakumar SB, Sen U. Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation. Pharmacol Res 2018;134:157-65. [PMID: 29909116 DOI: 10.1016/j.phrs.2018.06.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Sajdel-Sulkowska EM. A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency. Front Pharmacol 2021;12:684610. [PMID: 34177593 DOI: 10.3389/fphar.2021.684610] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Li Q, Grant MB, Richards EM, Raizada MK. ACE2 as therapeutic agent. Clin Sci (Lond) 2020;134:2581-95. [PMID: 33063820 DOI: 10.1042/CS20200570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
21 Abais-Battad JM, Saravia FL, Lund H, Dasinger JH, Fehrenbach DJ, Alsheikh AJ, Zemaj J, Kirby JR, Mattson DL. Dietary influences on the Dahl SS rat gut microbiota and its effects on salt-sensitive hypertension and renal damage. Acta Physiol (Oxf) 2021;232:e13662. [PMID: 33866692 DOI: 10.1111/apha.13662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Di Pierro F, Pane M. Bifidobacterium longum W11: Uniqueness and individual or combined clinical use in association with rifaximin. Clin Nutr ESPEN 2021;42:15-21. [PMID: 33745570 DOI: 10.1016/j.clnesp.2020.12.025] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kim TT, Parajuli N, Sung MM, Bairwa SC, Levasseur J, Soltys CM, Wishart DS, Madsen K, Schertzer JD, Dyck JRB. Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice. Am J Physiol Endocrinol Metab 2018;315:E511-9. [PMID: 29870676 DOI: 10.1152/ajpendo.00471.2017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
24 Su J, Xu HT, Yu JJ, Yan MQ, Wang T, Wu YJ, Li B, Lu WJ, Wang C, Lei SS, Chen SM, Chen SH, Lv GY. Luteolin ameliorates lipopolysaccharide-induced microcirculatory disturbance through inhibiting leukocyte adhesion in rat mesenteric venules. BMC Complement Med Ther 2021;21:33. [PMID: 33446171 DOI: 10.1186/s12906-020-03196-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Poggiogalle E, Fontana M, Giusti AM, Pinto A, Iannucci G, Lenzi A, Donini LM. Amino Acids and Hypertension in Adults. Nutrients 2019;11:E1459. [PMID: 31252583 DOI: 10.3390/nu11071459] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
26 Hsu CN, Tain YL. The First Thousand Days: Kidney Health and Beyond. Healthcare (Basel) 2021;9:1332. [PMID: 34683012 DOI: 10.3390/healthcare9101332] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Li J, Raizada MK, Richards EM. Gut-brain-bone marrow axis in hypertension. Curr Opin Nephrol Hypertens 2021;30:159-65. [PMID: 33394733 DOI: 10.1097/MNH.0000000000000678] [Reference Citation Analysis]
28 Oliveira AC, Richards EM, Raizada MK. Pulmonary hypertension: Pathophysiology beyond the lung. Pharmacol Res 2020;151:104518. [PMID: 31730803 DOI: 10.1016/j.phrs.2019.104518] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
29 Stevens BR, Pepine CJ, Richards EM, Kim S, Raizada MK. Depressive hypertension: A proposed human endotype of brain/gut microbiome dysbiosis. Am Heart J 2021;239:27-37. [PMID: 33984318 DOI: 10.1016/j.ahj.2021.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Petyaev IM, Bashmakov YK. Dark Chocolate: Opportunity for an Alliance between Medical Science and the Food Industry? Front Nutr 2017;4:43. [PMID: 29034240 DOI: 10.3389/fnut.2017.00043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
31 Beltrán-Barrientos LM, García HS, Hernández-Mendoza A, González-Córdova AF, Vallejo-Cordoba B. Invited review: Effect of antihypertensive fermented milks on gut microbiota. J Dairy Sci 2021;104:3779-88. [PMID: 33752288 DOI: 10.3168/jds.2020-19466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Polychronopoulou E, Braconnier P, Burnier M. New Insights on the Role of Sodium in the Physiological Regulation of Blood Pressure and Development of Hypertension. Front Cardiovasc Med 2019;6:136. [PMID: 31608291 DOI: 10.3389/fcvm.2019.00136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
33 Magalhães NS, Savino W, Silva PMR, Martins MA, Carvalho VF. Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients. Front Med (Lausanne) 2021;8:644751. [PMID: 34458281 DOI: 10.3389/fmed.2021.644751] [Reference Citation Analysis]
34 Li J, Yang X, Zhou X, Cai J. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development. Antioxid Redox Signal 2021;34:811-30. [PMID: 32316741 DOI: 10.1089/ars.2020.8104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 Thomaz FS, Altemani F, Panchal SK, Worrall S, Dekker Nitert M. The influence of wasabi on the gut microbiota of high-carbohydrate, high-fat diet-induced hypertensive Wistar rats. J Hum Hypertens 2021;35:170-80. [PMID: 32457512 DOI: 10.1038/s41371-020-0359-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Xu X, Ye D, Liu B, Yang Y, Chen Y, Qian Y, Mao Y, Sun X. Assessing the impact of blood pressure in the development of inflammatory bowel disease. J Clin Hypertens (Greenwich) 2022. [PMID: 35363426 DOI: 10.1111/jch.14477] [Reference Citation Analysis]
37 Ma Z, Hummel SL, Sun N, Chen Y. From salt to hypertension, what is missed? J Clin Hypertens (Greenwich) 2021;23:2033-41. [PMID: 34846798 DOI: 10.1111/jch.14402] [Reference Citation Analysis]
38 Razavi AC, Potts KS, Kelly TN, Bazzano LA. Sex, gut microbiome, and cardiovascular disease risk. Biol Sex Differ 2019;10:29. [PMID: 31182162 DOI: 10.1186/s13293-019-0240-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]
39 Walejko JM, Kim S, Goel R, Handberg EM, Richards EM, Pepine CJ, Raizada MK. Gut microbiota and serum metabolite differences in African Americans and White Americans with high blood pressure. Int J Cardiol 2018;271:336-9. [PMID: 30049487 DOI: 10.1016/j.ijcard.2018.04.074] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
40 Baptista LC, Sun Y, Carter CS, Buford TW. Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty. Front Nutr 2020;7:17. [PMID: 32219095 DOI: 10.3389/fnut.2020.00017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Jezova D, Karailiev P, Karailievova L, Puhova A, Murck H. Food Enrichment with Glycyrrhiza glabra Extract Suppresses ACE2 mRNA and Protein Expression in Rats-Possible Implications for COVID-19. Nutrients 2021;13:2321. [PMID: 34371831 DOI: 10.3390/nu13072321] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Wang YJ, Su J, Yu JJ, Yan MQ, Shi ML, Huang QD, Li B, Wu WY, Xia RS, Li SF, Chen SH, Lv GY. Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway. Front Pharmacol 2021;12:755140. [PMID: 34690786 DOI: 10.3389/fphar.2021.755140] [Reference Citation Analysis]
43 Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15:367-385. [PMID: 31015582 DOI: 10.1038/s41581-019-0145-4] [Cited by in Crossref: 103] [Cited by in F6Publishing: 104] [Article Influence: 51.5] [Reference Citation Analysis]
44 Yang T, Richards EM, Pepine CJ, Raizada MK. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol 2018;14:442-56. [PMID: 29760448 DOI: 10.1038/s41581-018-0018-2] [Cited by in Crossref: 133] [Cited by in F6Publishing: 131] [Article Influence: 44.3] [Reference Citation Analysis]
45 de Almeida Silva M, Mowry FE, Peaden SC, Andrade TU, Biancardi VC. Kefir ameliorates hypertension via gut–brain mechanisms in spontaneously hypertensive rats. The Journal of Nutritional Biochemistry 2020;77:108318. [DOI: 10.1016/j.jnutbio.2019.108318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
46 Hwang AY, Dietrich E, Pepine CJ, Smith SM. Resistant Hypertension: Mechanisms and Treatment. Curr Hypertens Rep. 2017;19:56. [PMID: 28597403 DOI: 10.1007/s11906-017-0754-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
47 Zhang Z, Zhao J, Tian C, Chen X, Li H, Wei X, Lin W, Zheng N, Jiang A, Feng R, Yuan J, Zhao X. Targeting the Gut Microbiota to Investigate the Mechanism of Lactulose in Negating the Effects of a High-Salt Diet on Hypertension. Mol Nutr Food Res 2019;63:e1800941. [PMID: 30825362 DOI: 10.1002/mnfr.201800941] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
48 Palmu J, Salosensaari A, Havulinna AS, Cheng S, Inouye M, Jain M, Salido RA, Sanders K, Brennan C, Humphrey GC, Sanders JG, Vartiainen E, Laatikainen T, Jousilahti P, Salomaa V, Knight R, Lahti L, Niiranen TJ. Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals. J Am Heart Assoc 2020;9:e016641. [PMID: 32691653 DOI: 10.1161/JAHA.120.016641] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
49 Vamanu E, Rai SN. The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis. Diseases 2021;9:45. [PMID: 34201465 DOI: 10.3390/diseases9030045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ou Y, Zhang C, Yao M, Wang L. Gut Flora: Novel Therapeutic Target of Chinese Medicine for the Treatment of Cardiovascular Diseases. Evid Based Complement Alternat Med 2019;2019:3719596. [PMID: 31531111 DOI: 10.1155/2019/3719596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
51 Edwards JM, Roy S, Galla SL, Tomcho JC, Bearss NR, Waigi EW, Mell B, Cheng X, Saha P, Vijay-Kumar M, McCarthy CG, Joe B, Wenceslau CF. FPR-1 (Formyl Peptide Receptor-1) Activation Promotes Spontaneous, Premature Hypertension in Dahl Salt-Sensitive Rats. Hypertension 2021;77:1191-202. [PMID: 33641367 DOI: 10.1161/HYPERTENSIONAHA.120.16237] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Li H, Liu B, Song J, An Z, Zeng X, Li J, Jiang J, Xie L, Wu W. Characteristics of Gut Microbiota in Patients with Hypertension and/or Hyperlipidemia: A Cross-Sectional Study on Rural Residents in Xinxiang County, Henan Province. Microorganisms 2019;7:E399. [PMID: 31561625 DOI: 10.3390/microorganisms7100399] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
53 Sircana A, De Michieli F, Parente R, Framarin L, Leone N, Berrutti M, Paschetta E, Bongiovanni D, Musso G. Gut microbiota, hypertension and chronic kidney disease: Recent advances. Pharmacol Res 2019;144:390-408. [PMID: 29378252 DOI: 10.1016/j.phrs.2018.01.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
54 Ahrens AP, Culpepper T, Saldivar B, Anton S, Stoll S, Handberg EM, Xu K, Pepine C, Triplett EW, Aggarwal M. A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study. Nutrients 2021;13:3459. [PMID: 34684459 DOI: 10.3390/nu13103459] [Reference Citation Analysis]
55 Yan Q, Zhai W, Yang C, Li Z, Mao L, Zhao M, Wu X. The Relationship among Physical Activity, Intestinal Flora, and Cardiovascular Disease. Cardiovasc Ther 2021;2021:3364418. [PMID: 34729078 DOI: 10.1155/2021/3364418] [Reference Citation Analysis]
56 Chakraborty S, Mandal J, Yang T, Cheng X, Yeo JY, McCarthy CG, Wenceslau CF, Koch LG, Hill JW, Vijay-Kumar M, Joe B. Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award. Hypertension 2020;75:1386-96. [PMID: 32336227 DOI: 10.1161/HYPERTENSIONAHA.120.13896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
57 Grylls A, Seidler K, Neil J. Link between microbiota and hypertension: Focus on LPS/TLR4 pathway in endothelial dysfunction and vascular inflammation, and therapeutic implication of probiotics. Biomed Pharmacother 2021;137:111334. [PMID: 33556874 DOI: 10.1016/j.biopha.2021.111334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Osman MM, El-khatib FM, Roberts NH, Huynh LM, Yafi FA. The Gut Microbiome and Men’s Sexual Health. Curr Sex Health Rep 2019;11:348-57. [DOI: 10.1007/s11930-019-00230-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Becerril-Alarcón Y, Campos-Gómez S, Valdez-Andrade JJ, Campos-Gómez KA, Reyes-Barretero DY, Benítez-Arciniega AD, Valdés-Ramos R, Soto-Piña AE. Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy. Cardiovasc Ther 2019;2019:5707150. [PMID: 31772611 DOI: 10.1155/2019/5707150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Hsu CN, Hou CY, Hsu WH, Tain YL. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy. Nutrients 2021;13:2290. [PMID: 34371800 DOI: 10.3390/nu13072290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, Mohammed M, Handberg EM, Richards EM, Pepine CJ, Raizada MK. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci (Lond) 2018;132:701-18. [PMID: 29507058 DOI: 10.1042/CS20180087] [Cited by in Crossref: 148] [Cited by in F6Publishing: 80] [Article Influence: 37.0] [Reference Citation Analysis]
62 Hsu CN, Hou CY, Chang-Chien GP, Lin S, Chan JYH, Lee CT, Tain YL. Maternal resveratrol therapy protected adult rat offspring against hypertension programmed by combined exposures to asymmetric dimethylarginine and trimethylamine-N-oxide. J Nutr Biochem 2021;93:108630. [PMID: 33798707 DOI: 10.1016/j.jnutbio.2021.108630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Richards EM, Raizada MK. ACE2 and pACE2: A Pair of Aces for Pulmonary Arterial Hypertension Treatment? Am J Respir Crit Care Med 2018;198:422-3. [PMID: 29634285 DOI: 10.1164/rccm.201803-0569ED] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
64 Liu H, Zhuang J, Tang P, Li J, Xiong X, Deng H. The Role of the Gut Microbiota in Coronary Heart Disease. Curr Atheroscler Rep 2020;22:77. [PMID: 33063240 DOI: 10.1007/s11883-020-00892-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
65 Xie W, Strong JA, Zhang JM. Localized sympathectomy reduces peripheral nerve regeneration and pain behaviors in 2 rat neuropathic pain models. Pain 2020;161:1925-36. [PMID: 32701850 DOI: 10.1097/j.pain.0000000000001887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Overby HB, Ferguson JF. Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension. Curr Hypertens Rep 2021;23:8. [PMID: 33537923 DOI: 10.1007/s11906-020-01125-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
67 Ferdinand KC, Graham RM. Disparities in hypertension and cardiovascular disease in African Americans: Is the answer in the gut microbiota? International Journal of Cardiology 2018;271:340-2. [DOI: 10.1016/j.ijcard.2018.06.096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
68 Chi C, Li C, Wu D, Buys N, Wang W, Fan H, Sun J. Effects of Probiotics on Patients with Hypertension: a Systematic Review and Meta-Analysis. Curr Hypertens Rep 2020;22:34. [PMID: 32200440 DOI: 10.1007/s11906-020-01042-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]